Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added a comprehensive Locations section listing trial sites across the US and Canada (and included multiple provinces), reflecting expanded site availability. The previous location sublists and the HHS Vulnerability Disclosure link were removed or updated, accompanying a Revision: v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-19T10:52:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.1 to v3.3.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T23:28:52.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A PubMed auto-fill note was added and the revision tag updated to v3.3.1, replacing the previous PubMed note and revision label.
    Difference
    0.0%
    Check dated 2025-11-20T22:31:13.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added two new recruitment sites for Tainan, Taiwan (70403 and 710) and updated existing entries from 'Tainan City' to 'Tainan, Taiwan' for the same codes. The government funding status notice was removed.
    Difference
    0.1%
    Check dated 2025-11-13T16:54:29.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    No meaningful differences observed between the two screenshots; the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2025-10-30T11:16:34.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    - Replaced the older company/address block with a simplified company name addition and updated revision to v3.2.0. - Removed the older Daiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, Tokyo and updated to Daiichi Sankyo with revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-10-01T04:56:04.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.